Source link : https://www.newshealth.biz/health-news/increased-retinopathy-risk-seen-with-glp-1ras-for-diabetes/
Eleftheriadou A, Riley D, Zhao SS, et al. Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database. Diabetologia. Published online April 4, 2024. doi:10.1007/s00125-024-06132-5 Source link : https://www.medscape.com/s/viewarticle/increased-retinopathy-risk-seen-glp-1ras-diabetes-2024a10006zj?src=rss Author : Publish date […]
Author : News Health
Publish date : 2024-04-16 13:00:00
Copyright for syndicated content belongs to the linked Source.